Article in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06431958 (Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii), which is not on this map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT06431958 active not recruitingnot on this mapstarted 2024, after this paper: background citation
Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii
TypeobservationalSponsorUniversity Hospital, BrestRan2024 to 2026Enrolled300ConditionsPneumocystis Pneumonia
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 10 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 4 institutions in 1 country.
Luis PlaInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.
Anna AviñóCIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Spain.
Ramón EritjaCIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Spain.ORCID 0000-0001-5383-9334
Alba Ruiz-GaitánGrupo Acreditado de Infección Grave, Instituto de Investigación Sanitaria La Fe and Servicio de Microbiología, Hospital Universitari i Politècnic La Fe, Avenida Fernando Abril Martorell, 46026 Valencia, Spain.
Javier PemánGrupo Acreditado de Infección Grave, Instituto de Investigación Sanitaria La Fe and Servicio de Microbiología, Hospital Universitari i Politècnic La Fe, Avenida Fernando Abril Martorell, 46026 Valencia, Spain.
Vicente FriazaInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, 41013 Sevilla, Spain.
Enrique J CalderónInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, 41013 Sevilla, Spain.ORCID 0000-0002-3166-5086
Elena AznarInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.ORCID 0000-0003-0361-3876
Ramón Martínez-MáñezInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.ORCID 0000-0001-5873-9674
Sara Santiago-FelipeInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.
Universitat de València · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESHospital Universitari i Politècnic La Fe · ESInstituto de Biomedicina de Sevilla · ES
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Pneumocystis pneumonia (PcP) is a disease produced by the opportunistic infection of the fungus
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Triplex Hybridization-Based Nanosystem for the Rapid Screening of Pneumocystis Pneumonia in Clinical Samples. · full record | OpenQuestion